[Osteoprotegerin (OPG)].
Takahashi
Naoki
N
Division of Clinical Laboratories, University of Fukui Hospital.
Kimura
Hideki
H
Yoshida
Haruyoshi
H
D000856:Anorexia Nervosa / Q000175:diagnosis; D015415:Biomarkers / Q000097:blood; D002318:Cardiovascular Diseases / Q000175:diagnosis; D003920:Diabetes Mellitus / Q000175:diagnosis; D004797:Enzyme-Linked Immunosorbent Assay / Q000379:methods; D005260:Female; D006023:Glycoproteins / Q000097:blood*; D006801:Humans; D007674:Kidney Diseases / Q000175:diagnosis; D008297:Male; D009101:Multiple Myeloma / Q000175:diagnosis; D010001:Osteitis Deformans / Q000175:diagnosis; D053244:Osteoprotegerin; D011471:Prostatic Neoplasms / Q000175:diagnosis; D011933:Reagent Kits, Diagnostic; D018160:Receptors, Cytoplasmic and Nuclear / Q000097:blood*; D018124:Receptors, Tumor Necrosis Factor / Q000097:blood*; D012016:Reference Values; D013048:Specimen Handling; D001749:Urinary Bladder Neoplasms / Q000175:diagnosis
D015415:Biomarkers; D006023:Glycoproteins; D053244:Osteoprotegerin; D011933:Reagent Kits, Diagnostic; D018160:Receptors, Cytoplasmic and Nuclear; D018124:Receptors, Tumor Necrosis Factor; C506030:TNFRSF11B protein, human